Redeye concludes that Q2 was in line with sales estimates but included a higher cost base than expected. Automotive was below and Research above estimates. For Automotive, the expected ramp-up will be pushed forward somewhat but mid- and long-term estimates will be maintained. On a positive note, Smart Eye states a clear optimism about the upcoming procurements from OEM customers. Redeye will lower its valuation by around 5%.